Healthcare provider profile · identity verified

Luis A Rivera, MD

General Practice · DAVENPORT, FL · NPI 1679221287

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	998	419
Metformin Hcl	Metformin Hcl	575	229
Losartan Potassium	Losartan Potassium	429	180
Amlodipine Besylate	Amlodipine Besylate	400	162
Levothyroxine Sodium	Levothyroxine Sodium	394	149
Gabapentin	Gabapentin	321	158
Lisinopril	Lisinopril	312	129
Famotidine	Famotidine	266	126
Glipizide	Glipizide	246	99
Simvastatin	Simvastatin	194	90
Rosuvastatin Calcium	Rosuvastatin Calcium	189	89
Hydrochlorothiazide	Hydrochlorothiazide	178	72
Alendronate Sodium	Alendronate Sodium	162	68
Fluticasone Propionate	Fluticasone Propionate	150	79
Tamsulosin Hcl	Tamsulosin Hcl	147	68
Metoprolol Succinate	Metoprolol Succinate	139	57
Omeprazole	Omeprazole	139	70
Albuterol Sulfate Hfa	Albuterol Sulfate	137	63
Carvedilol	Carvedilol	122	48
Montelukast Sodium	Montelukast Sodium	122	52
Pantoprazole Sodium	Pantoprazole Sodium	119	59
Metoprolol Tartrate	Metoprolol Tartrate	107	46
Trazodone Hcl	Trazodone Hcl	101	54
Eliquis	Apixaban	96	36
Glimepiride	Glimepiride	90	45
Naproxen	Naproxen	88	66
Ozempic	Semaglutide	88	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	35
Furosemide	Furosemide	79	38
Clonidine Hcl	Clonidine Hcl	78	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	35
Pioglitazone Hcl	Pioglitazone Hcl	72	29
Vitamin D2	Ergocalciferol (Vitamin D2)	71	33
Meloxicam	Meloxicam	67	37
Clopidogrel	Clopidogrel Bisulfate	65	27
Donepezil Hcl	Donepezil Hcl	63	29
Fenofibrate	Fenofibrate	62	33
Metformin Hcl Er	Metformin Hcl	62	22
Methylprednisolone	Methylprednisolone	60	51
Januvia	Sitagliptin Phosphate	59	31
Allopurinol	Allopurinol	53	23
Prednisone	Prednisone	52	36
Trulicity	Dulaglutide	52	18
Farxiga	Dapagliflozin Propanediol	49	26
Atenolol	Atenolol	47	21
Diclofenac Sodium	Diclofenac Sodium	46	25
Enalapril Maleate	Enalapril Maleate	46	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	22
Tizanidine Hcl	Tizanidine Hcl	44	33
Lantus	Insulin Glargine,hum.Rec.Anlog	41	18
Azithromycin	Azithromycin	39	36
Pravastatin Sodium	Pravastatin Sodium	39	17
Sertraline Hcl	Sertraline Hcl	39	25
Jardiance	Empagliflozin	38	17
Dicyclomine Hcl	Dicyclomine Hcl	36	14
Fenofibrate	Fenofibrate Nanocrystallized	36	18
Ciclopirox	Ciclopirox	35	21
Ezetimibe	Ezetimibe	35	18
Triamcinolone Acetonide	Triamcinolone Acetonide	35	31
Irbesartan	Irbesartan	34	16
Meclizine Hcl	Meclizine Hcl	33	24
Valsartan	Valsartan	33	suppressed
Buspirone Hcl	Buspirone Hcl	30	17
Glipizide Er	Glipizide	29	14
Hydralazine Hcl	Hydralazine Hcl	29	12
Finasteride	Finasteride	28	13
Amitriptyline Hcl	Amitriptyline Hcl	26	12
Pentoxifylline	Pentoxifylline	26	17
Duloxetine Hcl	Duloxetine Hcl	24	12
Mirtazapine	Mirtazapine	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Memantine Hcl	Memantine Hcl	23	13
Spironolactone	Spironolactone	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Ibuprofen	Ibuprofen	21	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	12
Methotrexate	Methotrexate Sodium	20	12
Nifedipine Er	Nifedipine	20	11
Novolog Flexpen	Insulin Aspart	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Brilinta	Ticagrelor	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	15
Tradjenta	Linagliptin	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	15	suppressed
Ramipril	Ramipril	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	11
Gemfibrozil	Gemfibrozil	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Topiramate	Topiramate	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error